Close
Digital Health & Ai Innovation summit 2026
APE 2026

Content Team HHMGlobal

Daiichi Sankyo Enters Into Agreement with Servier Canada For Factor Xa Inhibitor Edoxaban

Daiichi Sankyo Co Limited announced that it has entered into an agreement with Servier Canada whereby Servier Canada will market the oral, once-daily anti-coagulant...

Rex Health Mart Pharmacy, Receives McKesson’s 2016 Pharmacy of the Year Award

Rex Pharmacy, a Health Mart pharmacy located in Atlantic, Iowa, has been named the 2016 Pharmacy of the Year Grand Prize Winner by McKesson...

Takeda Revises Collaboration Agreement with Amgen to Returns Certain Molecules, Products

Takeda Pharmaceutical Company Limited announced revisions on an existing collaboration agreement, under which Takeda had rights to develop and commercialize multiple molecules / products...

St Jude Medical Expands Portfolio with New CRT Pacing Technology

St. Jude Medical Expands Its Heart Failure Portfolio with SyncAV CRT Technology, Providing Physicians Another Option for Managing Patients Not Responsive to Other Therapies....

March of Dimes, UHG Launch Prenatal Care Program to Help Improve Health Outcomes

• UnitedHealth Group contributes $700,000 to help launch and evaluate new group prenatal care program for pregnant women• New program aims to reduce nation's preterm birth...

EC grants marketing authorisation to Odefsey in HIV

Gilead Sciences, Inc announced that the EC hs granted marketing authorization for the once-daily single tablet regimen (STR) Odefsey®(emtricitabine 200 mg/rilpivirine 25 mg/tenofovir alafenamide...

Allergan Plc Receives FDA Approval for AVYCAZ sNDA

Allergan plc a leading global pharmaceutical company, announced the U.S. FDA has approved the company's supplemental New Drug Application (sNDA) to update the label...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate »